HALEY COOPER: Open Payments
NPI 1992398333 · MIDWEST CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 79 payments from 19 companies in 2025. Trend: 2023 $675 · 2024 $871 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $245 |
| Lilly USA, LLC | 9 | $147 |
| Aimmune Therapeutics, Inc. | 6 | $146 |
| Novo Nordisk Inc | 14 | $139 |
| AstraZeneca Pharmaceuticals LP | 5 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $85 |
| PFIZER INC. | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| Abbott Laboratories | 3 | $48 |
| Organon LLC | 3 | $43 |
Products named: ZENPEP, JARDIANCE, UBRELVY, FARXIGA, QULIPTA, MOUNJARO, Ozempic, Kerendia.
Industry payments across OK — which companies pay providers there.
